glucagon like peptide 1 glp 1 receptor agonist medications Glucagon-like 1(GLP-1) agonists in the management of the patient with type 2diabetes mellitus and chronic kidney disease: an approach for the nephrologist Glucagon-like peptide-1 receptor internalisation controls

doi: 10.3390/cells11081372

Patients should inform the scheduling coordinator and procedural team about all medications, including GLP-1 receptor agonists or dual GIP/GLP-1 receptor agonists, with specific drug name, dose, and frequency

Furthermore, the increasing awareness of the cardiovascular and renal benefits of GLP-1 receptor agonists is further driving their uptake in the region

GLP-1RAs may help alleviate myocardial damage linked to chronic hyperglycaemia

AFFF (Aqueous Film Forming Foam) is a firefighting foam that has been linked to various health issues, including cancer, due to its PFAS (per- and polyfluoroalkyl substances) content